313
Views
0
CrossRef citations to date
0
Altmetric
Drug Profile

Relacorilant in recurrent ovarian cancer: clinical evidence and future perspectives

, , , , , , , & show all
Pages 649-655 | Received 27 Feb 2024, Accepted 28 May 2024, Published online: 11 Jun 2024

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.